Tennis Elbow. Tennis Elbow
Conditions
Interventions
Intervention 1: Treatment group:At baseline, dermal patches and TNG drops were given to the patients and they were instructed to drip 20 drops daily on the site with the greatest local pain of the el
Treatment - Drugs
Placebo
Treatment group:At baseline, dermal patches and TNG drops were given to the patients and they were instructed to drip 20 drops daily on the site with the greatest local pain of the elbow, and cover i
Control Group:At baseline, dermal patches and liquid paraffin drops were given to the patients and they were instructed to drip 20 drops daily on the site with the greatest local pain of the elbow, a
Sponsors
Vice chancellor for research, Islamic Azad University Tehran Medical Branch
Eligibility
Sex/Gender
All
Age
16 Years to No maximum
Inclusion criteria
Inclusion criteria: Inclusion criteria:Tennis Elbow patients; aged over 16 years to less than 3 months before the start of the trial; the symptoms have been involved. Exclusion criteria:Patients with heart disease who had a history of GTN; history of fracture or dislocation of the elbow or wrist; or those on the joints had surgery; who had a history of local injection of steroids in the past three months; those with neurological symptoms distal (nerve signals from the reference point) to the elbow; and those who were seronegative patients with enteropathy.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| In terms of pain during rest at night and daily activities as well as Maudsley’s test. Timepoint: Before treatment, 2, 4 and 6 weeks after treatment. Method of measurement: Doctor questionnaire and relevant.;In terms of tenderness at epicondyle. Timepoint: Before treatment, 2, 4 and 6 weeks after treatment. Method of measurement: With doctor visits and questionnaires.;In terms of pain at epicondyle. Timepoint: Before treatment, 2, 4 and 6 weeks after treatment. Method of measurement: With doctor visits and questionnaires. | — |
Secondary
| Measure | Time frame |
|---|---|
| Mild to moderate headache. Timepoint: Every six hours. Method of measurement: Diagnosis of the patient's pain. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Shahla Abolghasemi
Islamic Azad University Tehran Medical Branch
Outcome results
None listed